NICE rejects groundbreaking Alzheimer’s drugs: What it means for the UK
In a move that has triggered disappointment across the [...]
Economics in health: Improving productivity, addressing unmet needs and prevention in the NHS
How the NHS can optimise health outcomes in a time [...]
CF recognised as a Top UK Consulting Firm in Healthcare and Strategy by Consultancy UK
We’re proud to share that CF has been recognised [...]
A new era in Alzheimer’s diagnosis: What the FDA’s first approved blood test means for the UK
On 16 May 2025, the U.S. Food and Drug [...]
The cost of quick fixes: Aligning NHS capital investment with need
Amid rising demand, outdated infrastructure and pressing system transformation [...]
An overview of the NHS Model Integrated Care Board blueprint
Since their establishment in July 2022, there have been [...]
European Health Data Space: The EU’s Digital Health Framework
The European Health Data Space (EHDS) is a major [...]
CF launches regional headquarters in the Middle East
CF is pleased to announce the establishment of its [...]
CF launches regional headquarters in the Middle East
CF is pleased to announce the establishment of its [...]
NHS Performance Assessment Framework for 2025/26
The NHS is ushering in a new era of [...]
